Description
Mesoeye C71 represents the most advanced frontier in aesthetic medicine for the targeted treatment of the periorbital area. Unlike common dermal fillers, this medical device does not act as a mere mechanical volumizer; instead, it functions as a comprehensive biological repair system. Its exclusive formula was specifically engineered to tackle the three primary causes of eye-area aging: lymphatic stasis, capillary fragility, and collagen degradation.
The Science of Patented Peptides
The clinical success of Mesoeye C71 lies in its unique tri-active complex, which works in perfect synergy to restore the youthful vitality of the gaze:
-
PeriOrbital Peptide XP2: This revolutionary molecule directly targets vascular health. It works by relaxing arteriolar spasms and improving capillary permeability. The result is an instantaneous improvement in microcirculation, preventing the fluid stagnation that leads to chronic puffiness and swelling.
-
Hexapeptide-17: A powerful lymphatic drainage agent that stimulates the receptors of the lymphatic vessels. Its role is crucial for accelerating the elimination of toxins and excess fluids, drastically reducing under-eye bags and lightening dark circles caused by vascular congestion.
-
Dermo-Restructuring Complex (DRMC): A highly bioavailable blend of over 50 nutrients, including amino acids, vitamins, and nucleosides. This complex provides the fundamental building blocks for the regeneration of the extracellular matrix, promoting the synthesis of fresh collagen and elastin.
Clinical Indications and Benefits
Mesoeye C71 is the treatment of choice for patients presenting with complex aesthetic concerns that standard skin boosters cannot resolve. It is particularly indicated for:
-
Dark Circles and Dullness: It enhances tissue oxygenation, eliminating the bluish or dark tint under the eyes.
-
Edematous Under-Eye Bags: It reduces fluid accumulation by strengthening the lymphatic system.
-
Periorbital Wrinkles: It smooths out crow’s feet and fine expression lines by increasing dermal density.
-
Eyelid Laxity: It improves the tone of thin skin, making it more elastic, firm, and resilient.
Treatment Protocol and Results
The administration of Mesoeye C71 must be performed exclusively by a qualified medical professional using intradermal micro-injections (papule technique or micro-nappage).
-
Recommended Cycle: For optimal and long-lasting results, an initial course of 3 to 6 sessions is recommended, spaced approximately 7 to 10 days apart.
-
Visible Effects: Many patients notice a more rested and “open” gaze after the very first session. However, the maximum aesthetic and biological benefit manifests at the end of the full cycle, once collagen remodeling has reached maturity.
-
Maintenance: To preserve the youthful effect, it is advisable to repeat a maintenance session or a mini-cycle every 6 to 8 months.
Safety and Professional Reliability
Mesoeye C71 is a product of the highest biological safety, CE-certified, and free from animal-derived components. Its excellent biocompatibility minimizes the risk of adverse reactions or long-term complications. It is important to emphasize that this product is a non-volumetric treatment: it does not attract excessive water and does not create unwanted swelling (edema), making it perfect even for patients prone to orbital fluid retention. Sourcing through authorized wholesale supplies ensures the integrity of the cold chain and the absolute authenticity of every 1ml syringe.
Reviews
There are no reviews yet.